Business, energy, technology, markets and global industry news from Business News Today

iDose TR

PharmaDeviceNews iDose TR
Representative image of an intraocular lens procedure, illustrating how Alcon’s Clareon TruPlus launch could intensify competition in enhanced monofocal cataract lenses at ASCRS 2026.
Medical Devices & Diagnostics

Glaukos iDose TR cuts eye pressure beyond cataract surgery alone, but will the advantage last?

Glaukos iDose TR shows an additional 3.6 mmHg pressure reduction with cataract surgery. Examine the Phase 4 data and adoption implications.

Read More
Medical Devices & Diagnostics

Is Glaukos building a multi-franchise ophthalmology platform through Epioxa and glaucoma implants?

Glaukos heads to ASCRS 2026 with Epioxa and glaucoma data. Read what this could change for keratoconus, sustained therapy, and adoption.

Read More